Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Equity (Unaudited)

v3.22.0.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid In Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Jun. 30, 2020 $ 38 $ 145,072 $ (103,615)   $ 41,495
Balance (in Shares) at Jun. 30, 2020 37,990        
Common stock issued for cash, net of issuance costs 3,267   3,267
Common stock issued for cash, net of issuance costs (in Shares) 416        
Common stock issued in payment of note interest $ 1 243   244
Common stock issued in payment of note interest (in Shares) 31        
Stock-based compensation 2,027   2,027
Stock-based compensation (in Shares) 127        
Common stock issued for exercise of options 102   102
Common stock issued for exercise of options (in Shares) 18        
Net loss (11,950)   (11,950)
Balance at Sep. 30, 2020 $ 39 150,711 (115,565)   35,185
Balance (in Shares) at Sep. 30, 2020 38,582        
Common stock issued for cash, net of issuance costs $ 2 20,153   20,155
Common stock issued for cash, net of issuance costs (in Shares) 2,296        
Common stock issued in payment of note interest 244   244
Common stock issued in payment of note interest (in Shares) 33        
Stock-based compensation 2,066   2,066
Stock-based compensation (in Shares) 350        
Common stock issued for exercise of warrants 118   118
Common stock issued for exercise of warrants (in Shares) 33        
Common stock issued for exercise of options 422   422
Common stock issued for exercise of options (in Shares) 73        
ESPP purchase 204   204
ESPP purchase (in Shares) 32        
Net loss (11,910)   (11,910)
Balance at Dec. 31, 2020 $ 41 173,918 (127,475)   46,484
Balance (in Shares) at Dec. 31, 2020 41,399        
Balance at Jun. 30, 2021 $ 51 265,130 (147,771)   117,410
Balance (in Shares) at Jun. 30, 2021 51,236        
Common stock issued for cash, net of issuance costs $ 1 5,431   5,432
Common stock issued for cash, net of issuance costs (in Shares) 556        
Stock-based compensation 2,348   2,348
Stock-based compensation (in Shares) 237        
Common stock issued for exercise of warrants 24   24
Common stock issued for exercise of warrants (in Shares) 4        
Common stock issued for exercise of options 33   33
Common stock issued for exercise of options (in Shares) 5        
Net loss (12,849)   (12,849)
Balance at Sep. 30, 2021 $ 52 272,966 (160,620) 112,398
Balance (in Shares) at Sep. 30, 2021 52,038        
Common stock issued for cash, net of issuance costs $ 2 13,355 13,357
Common stock issued for cash, net of issuance costs (in Shares) 1,931        
Stock-based compensation 2,900 2,900
Stock-based compensation (in Shares) 356        
Common stock issued for exercise of warrants 33 33
Common stock issued for exercise of warrants (in Shares) 4        
Common stock issued for exercise of options 107 107
Common stock issued for exercise of options (in Shares) 15        
ESPP purchase $ 1 311 312
ESPP purchase (in Shares) 53        
Common stock issued in acquisition 2,297 2,297
Common stock issued in acquisition (in Shares) 263        
Noncontrolling interest acquired 7,510 7,510
Net loss (15,264) 18 (15,246)
Balance at Dec. 31, 2021 $ 55 $ 291,969 $ (175,884) $ 7,528 $ 123,668
Balance (in Shares) at Dec. 31, 2021 54,660